BACKGROUND: Patient, physician, and environmental factors were identified, and the authors examined the contribution of these factors to demographic and health variation in colonoscopy follow-up after a positive fecal occult blood test/fecal immunochemical test (FOBT/FIT) screening. METHODS: In total, 76,243 FOBT/FIT-positive patients were identified from 120 Veterans Health Administration (VHA) facilities between August 16, 2009 and March 20, 2011 and were followed for 6 months. Patient demographic (race/ethnicity, sex, age, marital status) and health characteristics (comorbidities), physician characteristics (training level, whether primary care provider) and behaviors (inappropriate FOBT/FIT screening), and environmental factors (geographic access, facility type) were identified from VHA administrative records. Patient behaviors (refusal, private sector colonoscopy use) were estimated with statistical text mining conducted on clinic notes, and follow-up predictors and adjusted rates were estimated using hierarchical logistic regression. RESULTS: Roughly 50% of individuals completed a colonoscopy at a VHA facility within 6 months. Age and comorbidity score were negatively associated with follow-up. Blacks were more likely to receive follow-up than whites. Environmental factors attenuated but did not fully account for these differences. Patient behaviors (refusal, private sector colonoscopy use) and physician behaviors (inappropriate screening) fully accounted for the small reverse race disparity and attenuated variation by age and comorbidity score. Patient behaviors (refusal and private sector colonoscopy use) contributed more to variation in follow-up rates than physician behaviors (inappropriate screening). CONCLUSIONS: In the VHA, blacks are more likely to receive colonoscopy follow-up for positive FOBT/FIT results than whites, and follow-up rates markedly decline with advancing age and comorbidity burden. Patient and physician behaviors explain race variation in follow-up rates and contribute to variation by age and comorbidity burden. Cancer 2017;123:3502-12. Published 2017. This article is a US Government work and is in the public domain in the USA.
INTRODUCTION
Colorectal cancer was diagnosed in an estimated 134,490 individuals and resulted in an estimated 49,190 deaths in 2016. 1 Routine screening can reduce the burden of this disease, and the US Preventive Services Task Force recommends several screening modalities. 2 The fecal occult blood test (FOBT) and the fecal immunochemical test (FIT) are common screening modalities in many settings, including the 2 largest health care systems in the United States (Kaiser Permanente and the Veterans Health Administration [VHA] ). 3, 4 However, the benefits of FOBT/FIT screening cannot be achieved unless positive results are followed by colonoscopy. Prior studies have documented gaps in colonoscopy follow-up rates among individuals who had positive FOBT/FIT results; and, in many settings, <60% of screenees receive follow-up before they are due for repeat screening. [5] [6] [7] [8] [9] [10] Understanding the reasons for these gaps is essential for guiding the development of effective strategies for closing them.
Prior studies have reported lower rates of colonoscopy follow-up for positive FOBT/FIT results associated with various demographic and health characteristics, including non-African American race, 11 Hispanic ethnicity, 12 female sex, [12] [13] [14] increasing age, 10, 13, 15, 16 and comorbidities, 10 but it is not clear whether these patterns are because of variation in patient behaviors (eg, refusal), physician behaviors (eg, potentially inappropriate screening among those with limited life expectancy or recent prior colonoscopy), or environmental factors, such as geographic access to colonoscopy. Two studies indicated that from 14% to 38% of patients lacking follow-up for positive FOBT/FIT results had documentation of refusal, comorbidity, or a contraindication that would preclude follow-up testing 8, 17 ; however, 1 of those studies was limited to patients ages 70 years, 17 and neither study examined demographic or health-related variation in reasons for lack of follow-up. It has been observed that variation in patient refusal of treatment contributes to age and race differences in the receipt of cancer therapy 18 ; however, to our knowledge, no studies to date have examined whether refusal and potentially inappropriate screening contribute to demographic and health-related differences in colonoscopy follow-up for positive FOBT/FIT results.
In the current study, we addressed this gap by examining the contribution of patient behavior (refusal), physician behavior (potentially inappropriate FOBT/FIT screening), and environmental factors (access) to demographic and health variation in colonoscopy after a positive FOBT/FIT result in a sample of adults ages 50 to 85 years receiving care at a VHA facility. We hypothesized that any observed differences in follow-up rates by patient age, race, and comorbidities would be explained by variation in refusal, inappropriate screening, and access.
MATERIALS AND METHODS

Setting and Participants
We identified patients who received positive FOBT/FIT results from 1 of 120 eligible VHA facilities between August 16, 2009 , and March 20, 2011, and followed them until September 30, 2011 for colonoscopy completion or documentation of potentially valid reasons for not completing colonoscopy. We identified positive FOBT/ FIT results from VHA laboratory records, as described previously, 19 using the codes provided in Supporting Materials 1 (see online supporting information). We defined FOBT/FIT-positive cases as any individual or multiple card series with 1 or more positive result cards. We restricted the sample to patients who received positive FOBT/FIT results from facilities that conducted at least 1400 FOBTs in 2009 to permit rigorous examination of facility-level variation in follow-up colonoscopy. 19 We excluded individuals if they were aged <50 or >85 years at the time of the positive FOBT/FIT result, had a diagnosis of colorectal cancer, or died during the follow-up interval. To minimize the number of patients with missing data, we also excluded those who received their positive FOBT/FIT result from a VHA Community-Based Outpatient Clinic (CBOC) that referred <70% of colonoscopies to 1 of the sampled facilities or from a facility in which >90% of patients were missing data from clinical notes that were necessary to assess refusal and private sector colonoscopy use. With these criteria, we identified 76,243 individuals who received positive FOBT/FIT results from 120 VHA facilities for the current analysis ( Fig. 1 ).
Data Sources and Measures
The dependent measure for our analysis was a completed follow-up colonoscopy at a VHA facility within 6 months of the date of a positive FOBT/FIT result. We used this follow-up window because, consistent with previous studies, 10 most individuals in the VHA who complete colonoscopy after a positive FOBT/FIT result do so within 6 months. We identified completed colonoscopies from VHA administrative data using the codes provided in Supporting Materials 2 (see online supporting information).
Predictors
Guided by the Diagnostic Evaluation Model, 20, 21 we distinguished between patient, physician, and environmental predictors of follow-up. The patient factors examined consisted of: demographic and health characteristics, including race/ethnicity (non-Hispanic white, Hispanic, black, American Indian, Asian or Pacific Islander), sex, age (ages 50-59, 60-64, 65-75, and 76-85 years), and marital status (married, widowed, other), Charlson comorbidity score for the year before the positive FOBT/FIT result (0, 1-2, or 3); mental health diagnoses (psychiatric only, substance abuse only, dual diagnosis, or none), personal history of colorectal polyps or benign neoplasms (International Classification of Diseases for Oncology, 9th revision, codes 211.3-211.4, 569.0, and v12.72), and behaviors (colonoscopy refusal, use of private sector colonoscopy for follow-up). We used statistical text mining to identify documentation of refusal and private colonoscopy using a validated algorithm, as previously described. 19 This algorithm searched consult, progress, primary care, and clinical reminder notes entered during the follow-up interval for key phrases associated with refusal or private sector colonoscopy use and assigned each positive FOBT or FIT patient with 2 continuous scores: 1 corresponding to the probability that their notes contained documentation of refusal, and 1 corresponding to the probability that their notes contained documentation of private sector colonoscopy use. We used the probabilities from statistical text mining to assign refusal and private sector colonoscopy status to each individual without VHA follow-up. The distributions for these probabilities were disparate and tended toward extreme values. Our intent was to gauge the sensitivity of the initial findings to these unobserved outcomes; so, rather than performing a complex Monte Carlo simulation study, we classified notes with a refusal probability .60 as indicating that the patient refused follow-up, and notes with a private sector colonoscopy probability .93 were classified as indicating that the patient pursued private sector colonoscopy. We selected these thresholds based on the probability distributions (Supporting Figs. 1 and 2; see online supporting information).
The physician factors examined included: physician characteristics, such as FOBT/FIT ordering provider training (physician, nurse practitioner or physician assistant, resident, nurse, or other staff) and whether the ordering physician was the patient's primary care provider; and the physician behavior of potentially inappropriate screening (ie, patient has limited life expectancy, VHA colonoscopy in prior 10 years).
The environmental factors examined consisted of geographic access indicators, including residence (urban, rural) and drive time to the nearest VHA specialty care facility (<30, 30-60, or >60 minutes), and FOBT/FIT ordering facility type (specialty care or CBOC). We used administrative data to identify all predictors.
Analysis
Hierarchical regression was used to model the odds of completing follow-up colonoscopy within 6 months to identify individual-level predictors of follow-up. These models incorporated random effects for facility and fixed effects for the measures listed in Table 1 . To select variables for the final model, we used a bootstrap resampling model-selection algorithm. 22 This involved constructing 500 bootstrap samples using a forward-selection algorithm with each individual sample to develop a bootstrapped model and retaining predictors that were selected in 90% of these models for inclusion in the final model. From the final model, we constructed modelbased odds ratios and least-square mean follow-up estimates for each measure (using the observed marginal distributions of other covariates). We did not hypothesize interactions between predictors and thus did not include interaction terms in the model.
To assess the sensitivity of estimates to patient and physician behaviors that might explain lack of VHA follow-up, we reran our models excluding individuals who potentially had been screened inappropriately (n 5 343 with limited life expectancy, n 5 11,987 with a prior colonoscopy); and we treated those who refused colonoscopy (n 5 7708), pursued private sector colonoscopy (n 5 8666), or both (n 5 2510) as having received follow-up. This study was reviewed and approved by the institutional review boards at the Minneapolis and Boston Veterans Affairs Healthcare Systems.
RESULTS
Patients were primarily non-Hispanic white (65%) men (96%) ages 50 to 75 years (89%) ( Table 1) . Roughly onehalf (54%) were married, 27% had 3 comorbidities, 68% had a mental health or substance-abuse diagnosis, and 20% had a personal history of polyps. The majority had their FOBT/FIT ordered by a physician (72%) who was their primary care provider (72%). Less than 1% had limited life expectancy, and 16% had a VHA colonoscopy in the prior 10 years. Roughly one-half (51%) lived in rural areas, 42% lived more than 60 minutes away from the nearest VHA specialty care facility, and 57% had their FOBT/FIT ordered at a CBOC. Among the 76,243 patients who had positive FOBT/ FIT results, 38,005 (50%) completed a colonoscopy at a VHA facility within 6 months; 7294 (10%) did not complete a colonoscopy but were potentially inappropriately screened, either because of limited life expectancy (0.27%) or because they had a recent prior colonoscopy at a VHA facility (9.29%); up to 13,863 (18%) did not complete a colonoscopy but either refused a VHA colonoscopy (7%), pursued a private sector colonoscopy (8%), or both (3%); and at least 17,010 (22%) had no reason documented for not completing a colonoscopy.
Patient Factors
With the exception of sex, residence, and provider type, all factors examined were significantly associated with follow-up rates in univariate models (Table 2) . Patient factors that were retained in the multivariate model included race/ethnicity, age, a personal history of polyps, and comorbidity score. Age (odds ratio, 2.01-3.10 for the younger vs oldest age category) was a strong independent predictor, corresponding to follow-up rate differences as large as 29 percentage points. A personal history of polyps (odds ratio, 2.57) was positively associated, and the Charlson score was negatively associated, with follow-up. Patients with Charlson scores 3 had follow-up rates 5 percentage points lower than those with a score of zero (46% vs 51%). We observed a small reverse race disparity, with blacks demonstrating follow-up rates 4 percentage points higher than whites.
Physician Factors
Patients whose FOBT/FIT was ordered by their primary care provider had follow-up rates that were 7 percentage points higher than those whose FOBT/FIT was not ordered by their primary care provider. Colonoscopy in the prior 10 years (odds ratio, 1.66) was the only indicator of potentially inappropriate screening included in the multivariate model. Those with no prior colonoscopy in the past 10 years had a follow-up rate 12 percentage points higher than those with a prior colonoscopy (51% vs 39%, respectively).
Environmental Factors
No geographic access measures were retained in the multivariate model, but those who had an FOBT/FIT ordered at a specialty care facility had follow-up rates that were 7 percentage points higher than those who had a test ordered at a CBOC.
After excluding potentially inappropriately screened individuals and treating patients who refused colonoscopy or pursued colonoscopy in the private sector as having received follow-up, the small differences by race/ethnicity were further attenuated (Fig. 2 , Supporting Table 1 ; see online supporting information), and the differences by age (Fig. 3, Supporting Table 1 ; see online supporting information) and Charlson score (Fig. 4 , Supporting Table 1 ; see online supporting information) were markedly attenuated. Patient behavior (refusals and private sector colonoscopy use) contributed more to the variation in follow-up rates by age, race, and Charlson score than physician behavior (inappropriate screening), although all 3 increased with age and Charlson score and were more common among whites than blacks (Figs. (2 and 3) , and 4).
DISCUSSION
The current study demonstrated that 50% of FOBT/FITpositive patients completed a follow-up colonoscopy in the VHA within 6 months; that age and comorbidities were negatively associated with follow-up; and that blacks were more likely to receive follow-up in the VHA than whites. Multivariate models controlling for environmental factors, including geographic access, attenuated but did not fully account for these differences. Adjusting for patient behaviors (refusal and private sector colonoscopy use) and physician behaviors (potentially inappropriate screening) fully accounted for the small reverse race disparity and markedly attenuated variation by age and comorbidities.
Our observation of the contribution of potentially inappropriate screening because of a recent prior colonoscopy to the follow-up rate is consistent with findings from prior studies, including 1 that identified recent colonoscopy as a prevalent reason for failure to complete follow-up and 2 that reported a strong association between colonoscopy history and follow-up of a positive FOBT/FIT result. 15, 16 Potentially inappropriate screening because of limited life expectancy was relatively rare in our sample (<1%), 17 as also documented in prior studies conducted in samples ages 50 to 75 years. 23 The frequency of refusal among those who failed to complete a colonoscopy we observed (14%-21%, depending on whether those who refused are combined with those who both refused and had private sector colonoscopy access) was similar to colonoscopy follow-up refusal rates reported in prior studies (range, 7%-26%). 12, 16, 17, 24, 25 Although prior studies have documented lower rates of colorectal cancer screening 26 and surveillance 27 among racial and ethnic minority groups, findings regarding race/ethnic variation in colonoscopy follow-up for positive FOBT/FIT results are mixed. One prior study conducted in a community practice 12 reported lower followup rates among Hispanics, but most prior studies have reported either no evidence of race/ethnic variation in follow-up 5, 10, 28 or higher follow-up rates among minorities. 16, 29, 30 In addition, compared with previous studies documenting higher refusal among blacks for invasive procedures and treatments, including coronary angiography [31] [32] [33] [34] and revascularization, 32, 35 we observed lower refusal rates among blacks than among whites. This may in part reflect the finding that blacks are more likely to rely solely on VHA care [36] [37] [38] [39] [40] [41] [42] and thus may be less likely to refuse because of access to private sector colonoscopy. The race variation in use of VHA care may be explained in part by well documented race variations in income, education, and insurance coverage, all of which are positively associated with greater use of non-VHA care among Veterans. 37, 39, 40 Our finding that age and comorbidities were negatively associated with follow-up is consistent with previous reports. 5, 10, 13, 16, 24, 43 Studies that demonstrated no significant association between follow-up and these factors either restricted the sample to the oldest age groups 17 or excluded those aged >75 years. 6, 12, 15, 44 It is not clear why the effects of age and comorbidity on follow-up were not fully explained by other patient characteristics, patient behaviors (refusal, private sector colonoscopy use), physician behaviors (inappropriate screening), or environmental factors. Possible explanations include: lower patient and provider motivation to aggressively pursue follow-up Original Article under circumstances of advanced age or severe comorbidity because of lower perceived benefits and greater perceived risks of colonoscopy; greater likelihood that those with advanced age and severe comorbidity experience acute health challenges and logistical barriers that compete with follow-up; or a failure to capture all refusal, private sector colonoscopy, and inappropriate screening with the measures employed.
This study has several strengths, including a large, nationally representative sample of patients and facilities; rigorous methodology for assessing the impact of inappropriate screening, refusal, and private sector colonoscopy use on variation in follow-up rates by patient demographic and health characteristics; and the ability to examine the association between environmental factors and follow-up rate estimates. However, we were not able to assess patient psychosocial reasons for lack of follow-up. Understanding the contribution of patient perspectives and experiences will likely be critical to developing effective interventions to improve follow-up rates. We also might have overestimated inappropriate screening, given that some consider FOBT/FIT screening conducted more than 5 years after a prior colonoscopy as clinically appropriate. In addition, because we did not link our sample with private sector medical records, our assumption that patients who pursued colonoscopy in the private sector actually completed a colonoscopy might lead to overestimates of follow-up rates. However, the finding from another study that only 2% of patients who did not complete a VHA colonoscopy and said they were pursuing colonoscopy in the private sector lacked a Medicare claim for a colonoscopy 17 suggests this overestimate is likely small. Finally, the VHA population is unique and may not generalize to other settings. However, as the largest integrated health care system in the United States, the VHA population does generalize to a substantial number of individuals, including non-VHA Medicare beneficiary populations. 45 
CONCLUSIONS
In the VHA setting, blacks are more likely to receive colonoscopy follow-up for positive FOBT/FIT results than whites, and follow-up rates significantly decline with advancing age and comorbidity burden. Patient behaviors (refusal, private sector colonoscopy use) and physician behaviors (inappropriate screening) explain race/ethnicity variation in follow-up rates and contribute to variation by age and comorbidity burden.
Implications for Practice
Our finding that geographic access metrics were not significant predictors of follow-up suggest that policies like the Veteran Choice and Accountability Act, which expand geographic access for Veterans by purchasing care from private sector providers, may not fully address existing gaps in follow-up. Inappropriate screening is an important, modifiable physician behavioral barrier to improving follow-up rates, and future efforts to optimize follow-up would benefit from implementing methods to reliably exclude those with recent colonoscopy from clinical reminders and other tools designed to prompt physicians to initiate colorectal cancer screening. The VHA has a system in place for tracking patients who have positive FOBT/FIT screens at the facility-level, but the extent to which this tool is used and whether and how well non-VHA colonoscopies are tracked at the facility level are unknown. Future improvement efforts might seek to enhance the functionality of this tool by assessing whether and how accurately non-VHA colonoscopy information is included and to encourage its use through leadership and resource support. Additional improvement efforts might evaluate approaches to reduce inappropriate screening. Implementing a centralized eligibility assessment and tracking system that incorporates information on prior colonoscopy history, age, comorbidities, and/or life expectancy is 1 promising strategy to explore.
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